nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—CYP2D6—epilepsy syndrome	0.366	1	CbGaD
Pindolol—HTR1B—telencephalic ventricle—epilepsy syndrome	0.00645	0.122	CbGeAlD
Pindolol—HTR1A—telencephalic ventricle—epilepsy syndrome	0.0052	0.0982	CbGeAlD
Pindolol—HTR1B—ganglion—epilepsy syndrome	0.00401	0.0758	CbGeAlD
Pindolol—HTR1A—ganglion—epilepsy syndrome	0.00324	0.0612	CbGeAlD
Pindolol—HTR1A—hindbrain—epilepsy syndrome	0.00246	0.0464	CbGeAlD
Pindolol—HTR1B—brainstem—epilepsy syndrome	0.00174	0.0329	CbGeAlD
Pindolol—HTR1B—forebrain—epilepsy syndrome	0.00168	0.0318	CbGeAlD
Pindolol—ADRB1—forebrain—epilepsy syndrome	0.00158	0.0299	CbGeAlD
Pindolol—HTR1B—telencephalon—epilepsy syndrome	0.00155	0.0292	CbGeAlD
Pindolol—ADRB1—telencephalon—epilepsy syndrome	0.00146	0.0275	CbGeAlD
Pindolol—HTR1A—brainstem—epilepsy syndrome	0.00141	0.0266	CbGeAlD
Pindolol—HTR1A—forebrain—epilepsy syndrome	0.00136	0.0257	CbGeAlD
Pindolol—CYP2D6—hindbrain—epilepsy syndrome	0.00133	0.0252	CbGeAlD
Pindolol—HTR1A—telencephalon—epilepsy syndrome	0.00125	0.0236	CbGeAlD
Pindolol—HTR1B—midbrain—epilepsy syndrome	0.00111	0.021	CbGeAlD
Pindolol—HTR1B—spinal cord—epilepsy syndrome	0.00108	0.0205	CbGeAlD
Pindolol—HTR1B—head—epilepsy syndrome	0.000964	0.0182	CbGeAlD
Pindolol—HTR1B—nervous system—epilepsy syndrome	0.000914	0.0173	CbGeAlD
Pindolol—ADRB1—head—epilepsy syndrome	0.000907	0.0171	CbGeAlD
Pindolol—HTR1A—midbrain—epilepsy syndrome	0.000897	0.0169	CbGeAlD
Pindolol—HTR1B—central nervous system—epilepsy syndrome	0.00088	0.0166	CbGeAlD
Pindolol—HTR1A—spinal cord—epilepsy syndrome	0.000876	0.0165	CbGeAlD
Pindolol—ADRB1—nervous system—epilepsy syndrome	0.00086	0.0162	CbGeAlD
Pindolol—ADRB1—central nervous system—epilepsy syndrome	0.000828	0.0156	CbGeAlD
Pindolol—HTR1A—head—epilepsy syndrome	0.000778	0.0147	CbGeAlD
Pindolol—CYP2D6—brainstem—epilepsy syndrome	0.000764	0.0144	CbGeAlD
Pindolol—CYP2D6—forebrain—epilepsy syndrome	0.000738	0.0139	CbGeAlD
Pindolol—HTR1A—nervous system—epilepsy syndrome	0.000738	0.0139	CbGeAlD
Pindolol—HTR1A—central nervous system—epilepsy syndrome	0.00071	0.0134	CbGeAlD
Pindolol—HTR1B—brain—epilepsy syndrome	0.000699	0.0132	CbGeAlD
Pindolol—HTR1A—cerebellum—epilepsy syndrome	0.000694	0.0131	CbGeAlD
Pindolol—CYP2D6—telencephalon—epilepsy syndrome	0.000678	0.0128	CbGeAlD
Pindolol—ADRB1—brain—epilepsy syndrome	0.000657	0.0124	CbGeAlD
Pindolol—HTR1A—brain—epilepsy syndrome	0.000564	0.0106	CbGeAlD
Pindolol—Carteolol—CYP2D6—epilepsy syndrome	0.000495	0.11	CrCbGaD
Pindolol—CYP2D6—head—epilepsy syndrome	0.000422	0.00798	CbGeAlD
Pindolol—Metoprolol—CYP2C19—epilepsy syndrome	0.000405	0.0896	CrCbGaD
Pindolol—CYP2D6—nervous system—epilepsy syndrome	0.000401	0.00756	CbGeAlD
Pindolol—Betaxolol—CYP2D6—epilepsy syndrome	0.000389	0.086	CrCbGaD
Pindolol—CYP2D6—central nervous system—epilepsy syndrome	0.000386	0.00728	CbGeAlD
Pindolol—CYP2D6—cerebellum—epilepsy syndrome	0.000377	0.00712	CbGeAlD
Pindolol—Bisoprolol—CYP2D6—epilepsy syndrome	0.000375	0.0831	CrCbGaD
Pindolol—Acebutolol—CYP2D6—epilepsy syndrome	0.000355	0.0787	CrCbGaD
Pindolol—Oxprenolol—CYP2D6—epilepsy syndrome	0.000353	0.0781	CrCbGaD
Pindolol—Alprenolol—CYP2D6—epilepsy syndrome	0.000323	0.0715	CrCbGaD
Pindolol—Nadolol—ABCB1—epilepsy syndrome	0.000315	0.0698	CrCbGaD
Pindolol—CYP2D6—brain—epilepsy syndrome	0.000306	0.00578	CbGeAlD
Pindolol—Metoprolol—CYP2D6—epilepsy syndrome	0.0003	0.0664	CrCbGaD
Pindolol—Atenolol—ABCB1—epilepsy syndrome	0.000275	0.0609	CrCbGaD
Pindolol—Acebutolol—ABCB1—epilepsy syndrome	0.000254	0.0562	CrCbGaD
Pindolol—Metoprolol—ABCB1—epilepsy syndrome	0.000214	0.0474	CrCbGaD
Pindolol—Propranolol—CYP2C19—epilepsy syndrome	0.000204	0.0452	CrCbGaD
Pindolol—Pruritus—Felbamate—epilepsy syndrome	0.000193	0.000502	CcSEcCtD
Pindolol—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000193	0.000502	CcSEcCtD
Pindolol—Diarrhoea—Diazepam—epilepsy syndrome	0.000193	0.000502	CcSEcCtD
Pindolol—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000193	0.000502	CcSEcCtD
Pindolol—Rash—Levetiracetam—epilepsy syndrome	0.000192	0.000499	CcSEcCtD
Pindolol—Dermatitis—Levetiracetam—epilepsy syndrome	0.000192	0.000499	CcSEcCtD
Pindolol—Asthenia—Zonisamide—epilepsy syndrome	0.000191	0.000498	CcSEcCtD
Pindolol—Mental disorder—Gabapentin—epilepsy syndrome	0.000191	0.000498	CcSEcCtD
Pindolol—Dry mouth—Valproic Acid—epilepsy syndrome	0.000191	0.000497	CcSEcCtD
Pindolol—Headache—Levetiracetam—epilepsy syndrome	0.00019	0.000496	CcSEcCtD
Pindolol—Dizziness—Vigabatrin—epilepsy syndrome	0.000189	0.000493	CcSEcCtD
Pindolol—Confusional state—Valproic Acid—epilepsy syndrome	0.000189	0.000492	CcSEcCtD
Pindolol—Pruritus—Zonisamide—epilepsy syndrome	0.000189	0.000492	CcSEcCtD
Pindolol—Flatulence—Gabapentin—epilepsy syndrome	0.000187	0.000488	CcSEcCtD
Pindolol—Oedema—Valproic Acid—epilepsy syndrome	0.000187	0.000488	CcSEcCtD
Pindolol—Bradycardia—Topiramate—epilepsy syndrome	0.000187	0.000487	CcSEcCtD
Pindolol—Nausea—Propofol—epilepsy syndrome	0.000187	0.000487	CcSEcCtD
Pindolol—Tension—Gabapentin—epilepsy syndrome	0.000187	0.000486	CcSEcCtD
Pindolol—Vomiting—Fosphenytoin—epilepsy syndrome	0.000187	0.000486	CcSEcCtD
Pindolol—Diarrhoea—Felbamate—epilepsy syndrome	0.000186	0.000486	CcSEcCtD
Pindolol—Vertigo—Pregabalin—epilepsy syndrome	0.000186	0.000485	CcSEcCtD
Pindolol—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000186	0.000485	CcSEcCtD
Pindolol—Dizziness—Diazepam—epilepsy syndrome	0.000186	0.000485	CcSEcCtD
Pindolol—Syncope—Pregabalin—epilepsy syndrome	0.000186	0.000484	CcSEcCtD
Pindolol—Rash—Fosphenytoin—epilepsy syndrome	0.000185	0.000482	CcSEcCtD
Pindolol—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000185	0.000481	CcSEcCtD
Pindolol—Nervousness—Gabapentin—epilepsy syndrome	0.000185	0.000481	CcSEcCtD
Pindolol—Asthenia—Clonazepam—epilepsy syndrome	0.000184	0.00048	CcSEcCtD
Pindolol—Headache—Fosphenytoin—epilepsy syndrome	0.000184	0.000479	CcSEcCtD
Pindolol—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000184	0.000478	CcSEcCtD
Pindolol—Palpitations—Pregabalin—epilepsy syndrome	0.000183	0.000477	CcSEcCtD
Pindolol—Asthenia—Phenytoin—epilepsy syndrome	0.000183	0.000477	CcSEcCtD
Pindolol—Nausea—Midazolam—epilepsy syndrome	0.000183	0.000476	CcSEcCtD
Pindolol—Hallucination—Topiramate—epilepsy syndrome	0.000183	0.000476	CcSEcCtD
Pindolol—Muscle spasms—Gabapentin—epilepsy syndrome	0.000183	0.000476	CcSEcCtD
Pindolol—Tachycardia—Valproic Acid—epilepsy syndrome	0.000183	0.000476	CcSEcCtD
Pindolol—Diarrhoea—Zonisamide—epilepsy syndrome	0.000183	0.000475	CcSEcCtD
Pindolol—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000182	0.000475	CcSEcCtD
Pindolol—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000182	0.000475	CcSEcCtD
Pindolol—Pruritus—Clonazepam—epilepsy syndrome	0.000182	0.000474	CcSEcCtD
Pindolol—Vomiting—Vigabatrin—epilepsy syndrome	0.000182	0.000474	CcSEcCtD
Pindolol—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000181	0.000471	CcSEcCtD
Pindolol—Pruritus—Phenytoin—epilepsy syndrome	0.000181	0.000471	CcSEcCtD
Pindolol—Nausea—Levetiracetam—epilepsy syndrome	0.000181	0.00047	CcSEcCtD
Pindolol—Rash—Vigabatrin—epilepsy syndrome	0.00018	0.00047	CcSEcCtD
Pindolol—Dizziness—Felbamate—epilepsy syndrome	0.00018	0.000469	CcSEcCtD
Pindolol—Dermatitis—Vigabatrin—epilepsy syndrome	0.00018	0.000469	CcSEcCtD
Pindolol—Pruritus—Oxcarbazepine—epilepsy syndrome	0.00018	0.000468	CcSEcCtD
Pindolol—Headache—Vigabatrin—epilepsy syndrome	0.000179	0.000467	CcSEcCtD
Pindolol—Vomiting—Diazepam—epilepsy syndrome	0.000179	0.000466	CcSEcCtD
Pindolol—Tremor—Gabapentin—epilepsy syndrome	0.000178	0.000464	CcSEcCtD
Pindolol—Rash—Diazepam—epilepsy syndrome	0.000178	0.000462	CcSEcCtD
Pindolol—Dermatitis—Diazepam—epilepsy syndrome	0.000177	0.000462	CcSEcCtD
Pindolol—Visual impairment—Topiramate—epilepsy syndrome	0.000177	0.000461	CcSEcCtD
Pindolol—Arthralgia—Pregabalin—epilepsy syndrome	0.000177	0.00046	CcSEcCtD
Pindolol—Myalgia—Pregabalin—epilepsy syndrome	0.000177	0.00046	CcSEcCtD
Pindolol—Chest pain—Pregabalin—epilepsy syndrome	0.000177	0.00046	CcSEcCtD
Pindolol—Dizziness—Zonisamide—epilepsy syndrome	0.000176	0.000459	CcSEcCtD
Pindolol—Headache—Diazepam—epilepsy syndrome	0.000176	0.000459	CcSEcCtD
Pindolol—Anxiety—Pregabalin—epilepsy syndrome	0.000176	0.000458	CcSEcCtD
Pindolol—Diarrhoea—Clonazepam—epilepsy syndrome	0.000176	0.000458	CcSEcCtD
Pindolol—Hypotension—Valproic Acid—epilepsy syndrome	0.000175	0.000456	CcSEcCtD
Pindolol—Asthenia—Carbamazepine—epilepsy syndrome	0.000175	0.000456	CcSEcCtD
Pindolol—Diarrhoea—Phenytoin—epilepsy syndrome	0.000175	0.000455	CcSEcCtD
Pindolol—Nausea—Fosphenytoin—epilepsy syndrome	0.000174	0.000454	CcSEcCtD
Pindolol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000174	0.000453	CcSEcCtD
Pindolol—Vomiting—Felbamate—epilepsy syndrome	0.000173	0.000451	CcSEcCtD
Pindolol—Dry mouth—Pregabalin—epilepsy syndrome	0.000173	0.00045	CcSEcCtD
Pindolol—Pruritus—Carbamazepine—epilepsy syndrome	0.000172	0.000449	CcSEcCtD
Pindolol—Rash—Felbamate—epilepsy syndrome	0.000172	0.000448	CcSEcCtD
Pindolol—Dermatitis—Felbamate—epilepsy syndrome	0.000172	0.000447	CcSEcCtD
Pindolol—Tinnitus—Topiramate—epilepsy syndrome	0.000171	0.000446	CcSEcCtD
Pindolol—Vertigo—Gabapentin—epilepsy syndrome	0.000171	0.000445	CcSEcCtD
Pindolol—Headache—Felbamate—epilepsy syndrome	0.000171	0.000445	CcSEcCtD
Pindolol—Confusional state—Pregabalin—epilepsy syndrome	0.000171	0.000444	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000171	0.000444	CcSEcCtD
Pindolol—Cardiac disorder—Topiramate—epilepsy syndrome	0.000171	0.000444	CcSEcCtD
Pindolol—Syncope—Gabapentin—epilepsy syndrome	0.000171	0.000444	CcSEcCtD
Pindolol—Dizziness—Clonazepam—epilepsy syndrome	0.00017	0.000443	CcSEcCtD
Pindolol—Nausea—Vigabatrin—epilepsy syndrome	0.00017	0.000442	CcSEcCtD
Pindolol—Vomiting—Zonisamide—epilepsy syndrome	0.00017	0.000442	CcSEcCtD
Pindolol—Insomnia—Valproic Acid—epilepsy syndrome	0.000169	0.000441	CcSEcCtD
Pindolol—Oedema—Pregabalin—epilepsy syndrome	0.000169	0.000441	CcSEcCtD
Pindolol—Asthenia—Lamotrigine—epilepsy syndrome	0.000169	0.00044	CcSEcCtD
Pindolol—Dizziness—Phenytoin—epilepsy syndrome	0.000169	0.00044	CcSEcCtD
Pindolol—Rash—Zonisamide—epilepsy syndrome	0.000168	0.000438	CcSEcCtD
Pindolol—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000168	0.000438	CcSEcCtD
Pindolol—Palpitations—Gabapentin—epilepsy syndrome	0.000168	0.000438	CcSEcCtD
Pindolol—Dermatitis—Zonisamide—epilepsy syndrome	0.000168	0.000438	CcSEcCtD
Pindolol—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000168	0.000438	CcSEcCtD
Pindolol—Nausea—Diazepam—epilepsy syndrome	0.000167	0.000436	CcSEcCtD
Pindolol—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000167	0.000435	CcSEcCtD
Pindolol—Headache—Zonisamide—epilepsy syndrome	0.000167	0.000435	CcSEcCtD
Pindolol—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000167	0.000435	CcSEcCtD
Pindolol—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000167	0.000434	CcSEcCtD
Pindolol—Angiopathy—Topiramate—epilepsy syndrome	0.000167	0.000434	CcSEcCtD
Pindolol—Pruritus—Lamotrigine—epilepsy syndrome	0.000167	0.000434	CcSEcCtD
Pindolol—Shock—Pregabalin—epilepsy syndrome	0.000167	0.000434	CcSEcCtD
Pindolol—Somnolence—Valproic Acid—epilepsy syndrome	0.000166	0.000433	CcSEcCtD
Pindolol—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000166	0.000432	CcSEcCtD
Pindolol—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000166	0.000431	CcSEcCtD
Pindolol—Tachycardia—Pregabalin—epilepsy syndrome	0.000165	0.00043	CcSEcCtD
Pindolol—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000165	0.000429	CcSEcCtD
Pindolol—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000164	0.000426	CcSEcCtD
Pindolol—Vomiting—Clonazepam—epilepsy syndrome	0.000163	0.000426	CcSEcCtD
Pindolol—Vomiting—Phenytoin—epilepsy syndrome	0.000162	0.000423	CcSEcCtD
Pindolol—Rash—Clonazepam—epilepsy syndrome	0.000162	0.000422	CcSEcCtD
Pindolol—Dermatitis—Clonazepam—epilepsy syndrome	0.000162	0.000422	CcSEcCtD
Pindolol—Chest pain—Gabapentin—epilepsy syndrome	0.000162	0.000422	CcSEcCtD
Pindolol—Arthralgia—Gabapentin—epilepsy syndrome	0.000162	0.000422	CcSEcCtD
Pindolol—Myalgia—Gabapentin—epilepsy syndrome	0.000162	0.000422	CcSEcCtD
Pindolol—Nausea—Felbamate—epilepsy syndrome	0.000162	0.000422	CcSEcCtD
Pindolol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000162	0.000421	CcSEcCtD
Pindolol—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000162	0.000421	CcSEcCtD
Pindolol—Fatigue—Valproic Acid—epilepsy syndrome	0.000161	0.00042	CcSEcCtD
Pindolol—Anxiety—Gabapentin—epilepsy syndrome	0.000161	0.00042	CcSEcCtD
Pindolol—Dizziness—Carbamazepine—epilepsy syndrome	0.000161	0.00042	CcSEcCtD
Pindolol—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000161	0.00042	CcSEcCtD
Pindolol—Headache—Clonazepam—epilepsy syndrome	0.000161	0.000419	CcSEcCtD
Pindolol—Rash—Phenytoin—epilepsy syndrome	0.000161	0.000419	CcSEcCtD
Pindolol—Mental disorder—Topiramate—epilepsy syndrome	0.000161	0.000419	CcSEcCtD
Pindolol—Dermatitis—Phenytoin—epilepsy syndrome	0.000161	0.000419	CcSEcCtD
Pindolol—Rash—Oxcarbazepine—epilepsy syndrome	0.00016	0.000417	CcSEcCtD
Pindolol—Pain—Valproic Acid—epilepsy syndrome	0.00016	0.000417	CcSEcCtD
Pindolol—Constipation—Valproic Acid—epilepsy syndrome	0.00016	0.000417	CcSEcCtD
Pindolol—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.00016	0.000417	CcSEcCtD
Pindolol—Headache—Phenytoin—epilepsy syndrome	0.00016	0.000417	CcSEcCtD
Pindolol—Headache—Oxcarbazepine—epilepsy syndrome	0.000159	0.000414	CcSEcCtD
Pindolol—Nausea—Zonisamide—epilepsy syndrome	0.000158	0.000413	CcSEcCtD
Pindolol—Dry mouth—Gabapentin—epilepsy syndrome	0.000158	0.000412	CcSEcCtD
Pindolol—Hypotension—Pregabalin—epilepsy syndrome	0.000158	0.000412	CcSEcCtD
Pindolol—Flatulence—Topiramate—epilepsy syndrome	0.000158	0.000411	CcSEcCtD
Pindolol—Tension—Topiramate—epilepsy syndrome	0.000157	0.000409	CcSEcCtD
Pindolol—Confusional state—Gabapentin—epilepsy syndrome	0.000156	0.000408	CcSEcCtD
Pindolol—Dizziness—Lamotrigine—epilepsy syndrome	0.000156	0.000406	CcSEcCtD
Pindolol—Nervousness—Topiramate—epilepsy syndrome	0.000155	0.000405	CcSEcCtD
Pindolol—Oedema—Gabapentin—epilepsy syndrome	0.000155	0.000404	CcSEcCtD
Pindolol—Vomiting—Carbamazepine—epilepsy syndrome	0.000155	0.000404	CcSEcCtD
Pindolol—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000154	0.000402	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000154	0.000402	CcSEcCtD
Pindolol—Muscle spasms—Topiramate—epilepsy syndrome	0.000154	0.000401	CcSEcCtD
Pindolol—Rash—Carbamazepine—epilepsy syndrome	0.000154	0.0004	CcSEcCtD
Pindolol—Dermatitis—Carbamazepine—epilepsy syndrome	0.000154	0.0004	CcSEcCtD
Pindolol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000153	0.000399	CcSEcCtD
Pindolol—Insomnia—Pregabalin—epilepsy syndrome	0.000153	0.000399	CcSEcCtD
Pindolol—Nausea—Clonazepam—epilepsy syndrome	0.000153	0.000398	CcSEcCtD
Pindolol—Headache—Carbamazepine—epilepsy syndrome	0.000153	0.000398	CcSEcCtD
Pindolol—Shock—Gabapentin—epilepsy syndrome	0.000153	0.000398	CcSEcCtD
Pindolol—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000152	0.000396	CcSEcCtD
Pindolol—Paraesthesia—Pregabalin—epilepsy syndrome	0.000152	0.000396	CcSEcCtD
Pindolol—Nausea—Phenytoin—epilepsy syndrome	0.000152	0.000395	CcSEcCtD
Pindolol—Tachycardia—Gabapentin—epilepsy syndrome	0.000151	0.000394	CcSEcCtD
Pindolol—Propranolol—CYP2D6—epilepsy syndrome	0.000151	0.0335	CrCbGaD
Pindolol—Dyspnoea—Pregabalin—epilepsy syndrome	0.000151	0.000393	CcSEcCtD
Pindolol—Nausea—Oxcarbazepine—epilepsy syndrome	0.000151	0.000393	CcSEcCtD
Pindolol—Somnolence—Pregabalin—epilepsy syndrome	0.00015	0.000392	CcSEcCtD
Pindolol—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.00015	0.000391	CcSEcCtD
Pindolol—Tremor—Topiramate—epilepsy syndrome	0.00015	0.00039	CcSEcCtD
Pindolol—Vomiting—Lamotrigine—epilepsy syndrome	0.00015	0.00039	CcSEcCtD
Pindolol—Rash—Lamotrigine—epilepsy syndrome	0.000149	0.000387	CcSEcCtD
Pindolol—Dermatitis—Lamotrigine—epilepsy syndrome	0.000148	0.000387	CcSEcCtD
Pindolol—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000148	0.000385	CcSEcCtD
Pindolol—Headache—Lamotrigine—epilepsy syndrome	0.000148	0.000384	CcSEcCtD
Pindolol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000146	0.000381	CcSEcCtD
Pindolol—Fatigue—Pregabalin—epilepsy syndrome	0.000146	0.00038	CcSEcCtD
Pindolol—Hypotension—Gabapentin—epilepsy syndrome	0.000145	0.000378	CcSEcCtD
Pindolol—Nausea—Carbamazepine—epilepsy syndrome	0.000145	0.000377	CcSEcCtD
Pindolol—Pain—Pregabalin—epilepsy syndrome	0.000145	0.000377	CcSEcCtD
Pindolol—Constipation—Pregabalin—epilepsy syndrome	0.000145	0.000377	CcSEcCtD
Pindolol—Vertigo—Topiramate—epilepsy syndrome	0.000144	0.000374	CcSEcCtD
Pindolol—Syncope—Topiramate—epilepsy syndrome	0.000143	0.000374	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000141	0.000368	CcSEcCtD
Pindolol—Palpitations—Topiramate—epilepsy syndrome	0.000141	0.000368	CcSEcCtD
Pindolol—Loss of consciousness—Topiramate—epilepsy syndrome	0.000141	0.000366	CcSEcCtD
Pindolol—Insomnia—Gabapentin—epilepsy syndrome	0.00014	0.000366	CcSEcCtD
Pindolol—Nausea—Lamotrigine—epilepsy syndrome	0.00014	0.000364	CcSEcCtD
Pindolol—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000139	0.000363	CcSEcCtD
Pindolol—Paraesthesia—Gabapentin—epilepsy syndrome	0.000139	0.000363	CcSEcCtD
Pindolol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000138	0.00036	CcSEcCtD
Pindolol—Dyspnoea—Gabapentin—epilepsy syndrome	0.000138	0.00036	CcSEcCtD
Pindolol—Somnolence—Gabapentin—epilepsy syndrome	0.000138	0.000359	CcSEcCtD
Pindolol—Dyspepsia—Gabapentin—epilepsy syndrome	0.000137	0.000356	CcSEcCtD
Pindolol—Arthralgia—Topiramate—epilepsy syndrome	0.000136	0.000355	CcSEcCtD
Pindolol—Myalgia—Topiramate—epilepsy syndrome	0.000136	0.000355	CcSEcCtD
Pindolol—Chest pain—Topiramate—epilepsy syndrome	0.000136	0.000355	CcSEcCtD
Pindolol—Anxiety—Topiramate—epilepsy syndrome	0.000136	0.000354	CcSEcCtD
Pindolol—Asthenia—Valproic Acid—epilepsy syndrome	0.000134	0.00035	CcSEcCtD
Pindolol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000134	0.000349	CcSEcCtD
Pindolol—Fatigue—Gabapentin—epilepsy syndrome	0.000134	0.000348	CcSEcCtD
Pindolol—Abdominal pain—Pregabalin—epilepsy syndrome	0.000134	0.000348	CcSEcCtD
Pindolol—Dry mouth—Topiramate—epilepsy syndrome	0.000133	0.000347	CcSEcCtD
Pindolol—Constipation—Gabapentin—epilepsy syndrome	0.000133	0.000346	CcSEcCtD
Pindolol—Pain—Gabapentin—epilepsy syndrome	0.000133	0.000346	CcSEcCtD
Pindolol—Pruritus—Valproic Acid—epilepsy syndrome	0.000132	0.000345	CcSEcCtD
Pindolol—Confusional state—Topiramate—epilepsy syndrome	0.000132	0.000343	CcSEcCtD
Pindolol—Oedema—Topiramate—epilepsy syndrome	0.000131	0.00034	CcSEcCtD
Pindolol—Shock—Topiramate—epilepsy syndrome	0.000128	0.000335	CcSEcCtD
Pindolol—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000128	0.000334	CcSEcCtD
Pindolol—Nervous system disorder—Topiramate—epilepsy syndrome	0.000128	0.000333	CcSEcCtD
Pindolol—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000128	0.000333	CcSEcCtD
Pindolol—Tachycardia—Topiramate—epilepsy syndrome	0.000127	0.000332	CcSEcCtD
Pindolol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000127	0.000331	CcSEcCtD
Pindolol—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000126	0.000329	CcSEcCtD
Pindolol—Dizziness—Valproic Acid—epilepsy syndrome	0.000124	0.000322	CcSEcCtD
Pindolol—Abdominal pain—Gabapentin—epilepsy syndrome	0.000123	0.00032	CcSEcCtD
Pindolol—Hypotension—Topiramate—epilepsy syndrome	0.000122	0.000318	CcSEcCtD
Pindolol—Asthenia—Pregabalin—epilepsy syndrome	0.000121	0.000316	CcSEcCtD
Pindolol—Pruritus—Pregabalin—epilepsy syndrome	0.00012	0.000312	CcSEcCtD
Pindolol—Vomiting—Valproic Acid—epilepsy syndrome	0.000119	0.00031	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000119	0.00031	CcSEcCtD
Pindolol—Insomnia—Topiramate—epilepsy syndrome	0.000118	0.000308	CcSEcCtD
Pindolol—Rash—Valproic Acid—epilepsy syndrome	0.000118	0.000307	CcSEcCtD
Pindolol—Dermatitis—Valproic Acid—epilepsy syndrome	0.000118	0.000307	CcSEcCtD
Pindolol—Headache—Valproic Acid—epilepsy syndrome	0.000117	0.000305	CcSEcCtD
Pindolol—Paraesthesia—Topiramate—epilepsy syndrome	0.000117	0.000305	CcSEcCtD
Pindolol—Dyspnoea—Topiramate—epilepsy syndrome	0.000116	0.000303	CcSEcCtD
Pindolol—Somnolence—Topiramate—epilepsy syndrome	0.000116	0.000302	CcSEcCtD
Pindolol—Diarrhoea—Pregabalin—epilepsy syndrome	0.000116	0.000302	CcSEcCtD
Pindolol—Dyspepsia—Topiramate—epilepsy syndrome	0.000115	0.000299	CcSEcCtD
Pindolol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000113	0.000294	CcSEcCtD
Pindolol—Fatigue—Topiramate—epilepsy syndrome	0.000113	0.000293	CcSEcCtD
Pindolol—Dizziness—Pregabalin—epilepsy syndrome	0.000112	0.000291	CcSEcCtD
Pindolol—Pain—Topiramate—epilepsy syndrome	0.000112	0.000291	CcSEcCtD
Pindolol—Constipation—Topiramate—epilepsy syndrome	0.000112	0.000291	CcSEcCtD
Pindolol—Asthenia—Gabapentin—epilepsy syndrome	0.000111	0.00029	CcSEcCtD
Pindolol—Nausea—Valproic Acid—epilepsy syndrome	0.000111	0.00029	CcSEcCtD
Pindolol—Pruritus—Gabapentin—epilepsy syndrome	0.00011	0.000286	CcSEcCtD
Pindolol—Propranolol—ABCB1—epilepsy syndrome	0.000108	0.0239	CrCbGaD
Pindolol—Vomiting—Pregabalin—epilepsy syndrome	0.000108	0.00028	CcSEcCtD
Pindolol—Feeling abnormal—Topiramate—epilepsy syndrome	0.000108	0.00028	CcSEcCtD
Pindolol—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000107	0.000278	CcSEcCtD
Pindolol—Rash—Pregabalin—epilepsy syndrome	0.000107	0.000278	CcSEcCtD
Pindolol—Dermatitis—Pregabalin—epilepsy syndrome	0.000107	0.000278	CcSEcCtD
Pindolol—Diarrhoea—Gabapentin—epilepsy syndrome	0.000106	0.000277	CcSEcCtD
Pindolol—Headache—Pregabalin—epilepsy syndrome	0.000106	0.000276	CcSEcCtD
Pindolol—Abdominal pain—Topiramate—epilepsy syndrome	0.000103	0.000269	CcSEcCtD
Pindolol—Dizziness—Gabapentin—epilepsy syndrome	0.000103	0.000267	CcSEcCtD
Pindolol—Nausea—Pregabalin—epilepsy syndrome	0.000101	0.000262	CcSEcCtD
Pindolol—Vomiting—Gabapentin—epilepsy syndrome	9.87e-05	0.000257	CcSEcCtD
Pindolol—Rash—Gabapentin—epilepsy syndrome	9.79e-05	0.000255	CcSEcCtD
Pindolol—Dermatitis—Gabapentin—epilepsy syndrome	9.78e-05	0.000255	CcSEcCtD
Pindolol—Headache—Gabapentin—epilepsy syndrome	9.72e-05	0.000253	CcSEcCtD
Pindolol—Asthenia—Topiramate—epilepsy syndrome	9.37e-05	0.000244	CcSEcCtD
Pindolol—Pruritus—Topiramate—epilepsy syndrome	9.24e-05	0.000241	CcSEcCtD
Pindolol—Nausea—Gabapentin—epilepsy syndrome	9.22e-05	0.00024	CcSEcCtD
Pindolol—Diarrhoea—Topiramate—epilepsy syndrome	8.93e-05	0.000233	CcSEcCtD
Pindolol—Dizziness—Topiramate—epilepsy syndrome	8.63e-05	0.000225	CcSEcCtD
Pindolol—Vomiting—Topiramate—epilepsy syndrome	8.3e-05	0.000216	CcSEcCtD
Pindolol—Rash—Topiramate—epilepsy syndrome	8.23e-05	0.000214	CcSEcCtD
Pindolol—Dermatitis—Topiramate—epilepsy syndrome	8.22e-05	0.000214	CcSEcCtD
Pindolol—Headache—Topiramate—epilepsy syndrome	8.18e-05	0.000213	CcSEcCtD
Pindolol—Nausea—Topiramate—epilepsy syndrome	7.76e-05	0.000202	CcSEcCtD
Pindolol—ADRB3—Signaling Pathways—HTR2A—epilepsy syndrome	1.87e-05	9.73e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HSPB1—epilepsy syndrome	1.86e-05	9.69e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCL2—epilepsy syndrome	1.86e-05	9.69e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—OXT—epilepsy syndrome	1.86e-05	9.69e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCL3—epilepsy syndrome	1.86e-05	9.69e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CRH—epilepsy syndrome	1.86e-05	9.69e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ADAM10—epilepsy syndrome	1.86e-05	9.64e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.85e-05	9.6e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—CCL2—epilepsy syndrome	1.85e-05	9.59e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	1.84e-05	9.56e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CCR5—epilepsy syndrome	1.84e-05	9.56e-05	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.82e-05	9.44e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.81e-05	9.43e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	1.81e-05	9.42e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	1.81e-05	9.42e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—HTR2A—epilepsy syndrome	1.8e-05	9.35e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	1.79e-05	9.28e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TSC2—epilepsy syndrome	1.78e-05	9.24e-05	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.78e-05	9.23e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AGT—epilepsy syndrome	1.78e-05	9.23e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	1.77e-05	9.21e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	1.77e-05	9.21e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	1.76e-05	9.16e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	1.76e-05	9.16e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	1.76e-05	9.16e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—S100B—epilepsy syndrome	1.75e-05	9.11e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	1.75e-05	9.08e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	1.75e-05	9.08e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—APOE—epilepsy syndrome	1.74e-05	9.05e-05	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.74e-05	9.03e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SOCS3—epilepsy syndrome	1.74e-05	9.02e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PTK2B—epilepsy syndrome	1.73e-05	9.01e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TSC1—epilepsy syndrome	1.73e-05	9.01e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CDC42—epilepsy syndrome	1.73e-05	9e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.73e-05	8.96e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	1.72e-05	8.96e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	1.72e-05	8.96e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	1.72e-05	8.96e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	1.72e-05	8.93e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	1.71e-05	8.88e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AGT—epilepsy syndrome	1.71e-05	8.87e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—KDR—epilepsy syndrome	1.71e-05	8.86e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.7e-05	8.82e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.69e-05	8.77e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCR2—epilepsy syndrome	1.69e-05	8.76e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NTRK2—epilepsy syndrome	1.69e-05	8.76e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SST—epilepsy syndrome	1.69e-05	8.76e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	1.68e-05	8.73e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AVP—epilepsy syndrome	1.68e-05	8.72e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—DUSP6—epilepsy syndrome	1.67e-05	8.68e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	1.66e-05	8.61e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.66e-05	8.61e-05	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	1.66e-05	8.6e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADRA2A—epilepsy syndrome	1.65e-05	8.57e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.65e-05	8.57e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.65e-05	8.56e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.64e-05	8.54e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PLAT—epilepsy syndrome	1.64e-05	8.54e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PRKCB—epilepsy syndrome	1.64e-05	8.53e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL6ST—epilepsy syndrome	1.64e-05	8.5e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	1.63e-05	8.45e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	1.63e-05	8.45e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.62e-05	8.42e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	1.62e-05	8.42e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	1.62e-05	8.42e-05	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	1.62e-05	8.41e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.61e-05	8.39e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.61e-05	8.35e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	1.59e-05	8.27e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	1.59e-05	8.27e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	1.59e-05	8.25e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HES1—epilepsy syndrome	1.59e-05	8.24e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	1.59e-05	8.24e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCL12—epilepsy syndrome	1.59e-05	8.24e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—BDKRB2—epilepsy syndrome	1.59e-05	8.24e-05	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—POMC—epilepsy syndrome	1.58e-05	8.23e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PRKCB—epilepsy syndrome	1.58e-05	8.2e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL6ST—epilepsy syndrome	1.57e-05	8.17e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—JUNB—epilepsy syndrome	1.56e-05	8.09e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CNR1—epilepsy syndrome	1.56e-05	8.09e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	1.55e-05	8.07e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PLCB1—epilepsy syndrome	1.55e-05	8.06e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—FYN—epilepsy syndrome	1.54e-05	8.01e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	1.54e-05	8.01e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—H2AFX—epilepsy syndrome	1.54e-05	7.99e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MEF2C—epilepsy syndrome	1.53e-05	7.97e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HTR7—epilepsy syndrome	1.52e-05	7.89e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	1.51e-05	7.86e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	1.51e-05	7.83e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	1.5e-05	7.81e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—POMC—epilepsy syndrome	1.5e-05	7.77e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.49e-05	7.74e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.49e-05	7.74e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.48e-05	7.7e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	1.48e-05	7.69e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	1.48e-05	7.68e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HBEGF—epilepsy syndrome	1.47e-05	7.66e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	1.47e-05	7.64e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	1.47e-05	7.64e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NGF—epilepsy syndrome	1.47e-05	7.62e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CCL2—epilepsy syndrome	1.46e-05	7.6e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT3—epilepsy syndrome	1.45e-05	7.52e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	1.45e-05	7.51e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	1.44e-05	7.47e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—POMC—epilepsy syndrome	1.44e-05	7.47e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCR5—epilepsy syndrome	1.43e-05	7.41e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADAM10—epilepsy syndrome	1.41e-05	7.34e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CCL2—epilepsy syndrome	1.41e-05	7.31e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	1.4e-05	7.26e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HTR2A—epilepsy syndrome	1.4e-05	7.25e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	1.38e-05	7.19e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	1.38e-05	7.17e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	1.37e-05	7.1e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	1.35e-05	7.03e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	1.35e-05	7.01e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	1.34e-05	6.94e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	1.34e-05	6.94e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TSC2—epilepsy syndrome	1.33e-05	6.89e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AGT—epilepsy syndrome	1.32e-05	6.88e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	1.32e-05	6.87e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—FGF2—epilepsy syndrome	1.32e-05	6.87e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	1.32e-05	6.86e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	1.31e-05	6.79e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—APOE—epilepsy syndrome	1.3e-05	6.74e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	1.28e-05	6.64e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—KDR—epilepsy syndrome	1.27e-05	6.61e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	1.26e-05	6.56e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	1.24e-05	6.42e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	1.23e-05	6.38e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—RELA—epilepsy syndrome	1.23e-05	6.38e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	1.22e-05	6.36e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PRKCB—epilepsy syndrome	1.22e-05	6.36e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	1.22e-05	6.35e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6ST—epilepsy syndrome	1.22e-05	6.33e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.21e-05	6.31e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	1.21e-05	6.28e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MTOR—epilepsy syndrome	1.2e-05	6.26e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	1.2e-05	6.24e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	1.2e-05	6.22e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	1.2e-05	6.21e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.18e-05	6.15e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.18e-05	6.14e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.18e-05	6.11e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	1.18e-05	6.11e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.17e-05	6.08e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.17e-05	6.07e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	1.17e-05	6.07e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.16e-05	6e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	1.14e-05	5.94e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	1.14e-05	5.9e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.13e-05	5.87e-05	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.12e-05	5.81e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	1.12e-05	5.8e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—POMC—epilepsy syndrome	1.11e-05	5.79e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	1.11e-05	5.78e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	1.11e-05	5.77e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CASP3—epilepsy syndrome	1.11e-05	5.75e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCL2—epilepsy syndrome	1.09e-05	5.67e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	1.09e-05	5.65e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	1.09e-05	5.65e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—JUN—epilepsy syndrome	1.08e-05	5.59e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.06e-05	5.52e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	1.06e-05	5.49e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	1.05e-05	5.48e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MMP9—epilepsy syndrome	1.05e-05	5.44e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	1.03e-05	5.37e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	1.03e-05	5.37e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	1.03e-05	5.36e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—AKT1—epilepsy syndrome	1.02e-05	5.27e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	1.01e-05	5.26e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	1.01e-05	5.25e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.01e-05	5.25e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	1.01e-05	5.25e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	1.01e-05	5.24e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.01e-05	5.23e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	9.91e-06	5.15e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	9.89e-06	5.14e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	9.86e-06	5.12e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	9.75e-06	5.06e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	9.71e-06	5.04e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	9.69e-06	5.03e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SRC—epilepsy syndrome	9.65e-06	5.01e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	9.6e-06	4.99e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	9.54e-06	4.95e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	9.5e-06	4.93e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	9.5e-06	4.93e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TH—epilepsy syndrome	9.46e-06	4.92e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—VEGFA—epilepsy syndrome	9.4e-06	4.88e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	9.32e-06	4.84e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	9.29e-06	4.82e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	9.15e-06	4.75e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	8.97e-06	4.66e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	8.88e-06	4.61e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	8.69e-06	4.51e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	8.69e-06	4.51e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	8.5e-06	4.42e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	8.49e-06	4.41e-05	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	8.33e-06	4.33e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	8.31e-06	4.32e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	8.25e-06	4.29e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	8.02e-06	4.17e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	7.9e-06	4.1e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	7.85e-06	4.08e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	7.8e-06	4.05e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CAT—epilepsy syndrome	7.79e-06	4.05e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	7.68e-06	3.99e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	7.58e-06	3.94e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	7.57e-06	3.93e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	7.51e-06	3.9e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	7.29e-06	3.79e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	7.19e-06	3.74e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	7.15e-06	3.71e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	7.13e-06	3.7e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	7.05e-06	3.66e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	7e-06	3.64e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	6.99e-06	3.63e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	6.97e-06	3.62e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	6.84e-06	3.55e-05	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.64e-06	3.45e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	6.57e-06	3.42e-05	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	6.49e-06	3.37e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	6.43e-06	3.34e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	6.39e-06	3.32e-05	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.35e-06	3.3e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	6.29e-06	3.27e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	6.25e-06	3.25e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	6.21e-06	3.23e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AGT—epilepsy syndrome	6.18e-06	3.21e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	6.11e-06	3.17e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	6.08e-06	3.16e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOE—epilepsy syndrome	6.06e-06	3.15e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	6.03e-06	3.13e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AKT1—epilepsy syndrome	6e-06	3.12e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	5.94e-06	3.09e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	5.89e-06	3.06e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	5.76e-06	2.99e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	5.73e-06	2.98e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	5.6e-06	2.91e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	5.58e-06	2.9e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	5.48e-06	2.85e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	5.46e-06	2.84e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	5.34e-06	2.77e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—POMC—epilepsy syndrome	5.2e-06	2.7e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.74e-06	2.46e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	4.47e-06	2.32e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	4.15e-06	2.16e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	3.56e-06	1.85e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	3.48e-06	1.81e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	3.4e-06	1.77e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.09e-06	1.08e-05	CbGpPWpGaD
